|
|
HIV Infections - Prevention & control
Research News and Information
Definition of 'HIV Infections'Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). Common names: HIV Infections; HIV Infection; Infection, HIV; Infections, HIV; HTLV-III-LAV Infections; HTLV III LAV Infections; HTLV-III-LAV Infection; Infection, HTLV-III-LAV; Infections, HTLV-III-LAV; T-Lymphotropic Virus Type III Infections, Human; T Lymphotropic Virus Type III Infections, Human |
Saturday, November 21, 2009
13 Nov 2009
Given the central role that interleukin 15 (IL-15) plays in human immunodeficiency virus (HIV) immunity, we hypothesized that IL-15 in breast milk may protect against postnatal HIV transmission. In a nested case-control study, we compared breast ... Read more...
13 Nov 2009
BACKGROUND: The association between postnatal human immunodeficiency virus type 1 (HIV-1) transmission and maternal highly active antiretroviral therapy (HAART) after infant extended antiretroviral prophylaxis was assessed. METHODS: A follow-up ... Read more...
Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis.
30 Oct 2009
Male circumcision provides long-term indirect protection to women by reducing the risk of heterosexual men becoming infected with HIV. In this Review, we summarise the evidence for a direct effect of male circumcision on the risk of women becoming ... Read more...
Latest indexed articles for 'HIV Infections - Prevention & control'
These are the very latest articles for this heading:
- Microbicide development: positive women's concerns.
29 Nov 2009 - AIDS vaccine research and advocacy: an update.
29 Nov 2009 - High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission.
13 Nov 2009 - Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
13 Nov 2009 - Not our problem.
30 Oct 2009 - Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis.
30 Oct 2009 - HIV vaccine trials and tribulations.
30 Oct 2009 - Male circumcision for prevention of HIV transmission.
29 Oct 2009 - Male circumcision for prevention of HIV transmission.
29 Oct 2009 - Male circumcision and risk of HIV in women.
29 Oct 2009 - Clinical practice. Postexposure prophylaxis for HIV infection.
27 Oct 2009 - USA looks set to repeal HIV travel ban.
22 Oct 2009 - The myth of the virgin rape myth.
22 Oct 2009 - Abstracts of AIDS Vaccine 2009. Paris, France. October 19-22, 2009.
20 Oct 2009 - Effect of a point-of-use water treatment and safe water storage intervention on diarrhea in infants of HIV-infected mothers.
13 Oct 2009 - Strategies for Preventing HIV Transmission.
12 Oct 2009 - Strategies for preventing HIV transmission.
12 Oct 2009 - A road map to control malaria, tuberculosis, and human immunodeficiency virus/AIDS.
10 Oct 2009 - The future of harm reduction programmes in Russia.
8 Oct 2009 - Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania.
7 Oct 2009
See a longer list of these articles.
Technical information about 'HIV Infections'
Definition: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Descriptor UI: D015658
Alternative terms: HIV Infections; HIV Infection; Infection, HIV; Infections, HIV; HTLV-III-LAV Infections; HTLV III LAV Infections; HTLV-III-LAV Infection; Infection, HTLV-III-LAV; Infections, HTLV-III-LAV; T-Lymphotropic Virus Type III Infections, Human; T Lymphotropic Virus Type III Infections, Human; HTLV-III Infections; HTLV III Infections; HTLV-III Infection; Infection, HTLV-III; Infections, HTLV-III;
Related Mesh Headings: Lymphoma, AIDS-Related;
Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; transmission; urine; veterinary; ultrasonography; virology;
Tree Number: C02.782.815.616.400; C02.800.801.400; C20.673.480;
Online Note: use ACQUIRED IMMUNODEFICIENCY SYNDROME to search HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION 1989; HIV INFECTION 1988-89; HTLV-III INFECTION & HTLV-III LAV INFECTION 1987-89
History Note: 90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION & HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89
Technical Notes: caused by a lentivirus; GEN or unspecified; coord IM with HIV-1 (IM) or HIV-2 (IM); note specific indentions under HIV INFECTIONS; DF: HIV INFECT